Mukuto Shioda
Mibu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Real-world achievement of higher standards for migraine prevention with CGRP monoclonal antibodies.
Journal: Cephalalgia : an international journal of headache
Published: June 01, 2026
Interictal thermal pain hypersensitivity and central sensitization in migraine patients: a case-control study using quantitative sensory testing.
Journal: Head & face medicine
Published: January 17, 2026
A Real-World Study of CGRP Monoclonal Antibodies for Migraine: Long-Term Effectiveness and Treatment Adherence.
Journal: European journal of neurology
Published: November 11, 2025
A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 months.
Journal: Neurological research and practice
Published: April 22, 2025
The effect of calcitonin gene-related peptide monoclonal antibodies on restless legs syndrome in patients with migraine.
Journal: The journal of headache and pain
Published: January 07, 2025
Can calcitonin gene-related peptide monoclonal antibodies ameliorate writer's cramp and migraine?
Journal: Neuropsychopharmacology reports
Published: February 21, 2024
Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule.
Journal: Journal of the neurological sciences
Published: October 03, 2023
Real-world effectiveness of erenumab in Japanese patients with migraine.
Journal: Heliyon
Published: June 29, 2023
Anti-LGI1 encephalitis recurring 3 years after the first episode: a case report.
Journal: BMC neurology
Published: November 02, 2021
Transient glyphosate encephalopathy due to a suicide attempt.
Journal: Neuropsychopharmacology reports
Published: June 19, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026